ECKERT & ZIEGLER SE (EUZ.DE) Stock Fundamental Analysis
Europe - FRA:EUZ - DE0005659700 - Common Stock
15.66 EUR
-0.23 (-1.45%)
EUZ gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making EUZ a very profitable company, without any liquidiy or solvency issues. EUZ has a correct valuation and a medium growth rate. These ratings would make EUZ suitable for quality investing!
1. Profitability
1.1 Basic Checks
EUZ had positive earnings in the past year.
In the past year EUZ had a positive cash flow from operations.
Each year in the past 5 years EUZ has been profitable.
In the past 5 years EUZ always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 8.35%, EUZ belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
Looking at the Return On Equity, with a value of 16.32%, EUZ belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
The Return On Invested Capital of EUZ (12.73%) is better than 90.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EUZ is in line with the industry average of 9.00%.
The 3 year average ROIC (9.92%) for EUZ is below the current ROIC(12.73%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.35% | ||
| ROE | 16.32% | ||
| ROIC | 12.73% |
ROA(3y)6.9%
ROA(5y)7.6%
ROE(3y)13.51%
ROE(5y)14.72%
ROIC(3y)9.92%
ROIC(5y)9.15%
1.3 Margins
The Profit Margin of EUZ (12.24%) is better than 75.00% of its industry peers.
EUZ's Profit Margin has declined in the last couple of years.
EUZ has a Operating Margin of 21.68%. This is amongst the best in the industry. EUZ outperforms 88.33% of its industry peers.
In the last couple of years the Operating Margin of EUZ has grown nicely.
The Gross Margin of EUZ (47.96%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of EUZ has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.68% | ||
| PM (TTM) | 12.24% | ||
| GM | 47.96% |
OM growth 3Y9.05%
OM growth 5Y5.71%
PM growth 3Y-16.23%
PM growth 5Y-1.83%
GM growth 3Y-1.4%
GM growth 5Y-0.15%
2. Health
2.1 Basic Checks
EUZ has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
EUZ has about the same amout of shares outstanding than it did 1 year ago.
EUZ has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, EUZ has an improved debt to assets ratio.
2.2 Solvency
EUZ has an Altman-Z score of 4.87. This indicates that EUZ is financially healthy and has little risk of bankruptcy at the moment.
EUZ has a Altman-Z score of 4.87. This is amongst the best in the industry. EUZ outperforms 83.33% of its industry peers.
EUZ has a debt to FCF ratio of 0.86. This is a very positive value and a sign of high solvency as it would only need 0.86 years to pay back of all of its debts.
EUZ's Debt to FCF ratio of 0.86 is amongst the best of the industry. EUZ outperforms 88.33% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that EUZ is not too dependend on debt financing.
EUZ's Debt to Equity ratio of 0.18 is fine compared to the rest of the industry. EUZ outperforms 68.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 0.86 | ||
| Altman-Z | 4.87 |
ROIC/WACC1.81
WACC7.02%
2.3 Liquidity
EUZ has a Current Ratio of 3.04. This indicates that EUZ is financially healthy and has no problem in meeting its short term obligations.
EUZ's Current ratio of 3.04 is amongst the best of the industry. EUZ outperforms 81.67% of its industry peers.
A Quick Ratio of 3.00 indicates that EUZ has no problem at all paying its short term obligations.
The Quick ratio of EUZ (3.00) is better than 88.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.04 | ||
| Quick Ratio | 3 |
3. Growth
3.1 Past
EUZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.02%, which is quite good.
Measured over the past years, EUZ shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.65% on average per year.
EUZ shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.42%.
Measured over the past years, EUZ shows a quite strong growth in Revenue. The Revenue has been growing by 10.63% on average per year.
EPS 1Y (TTM)16.02%
EPS 3Y-1.23%
EPS 5Y8.65%
EPS Q2Q%24.4%
Revenue 1Y (TTM)9.42%
Revenue growth 3Y17.92%
Revenue growth 5Y10.63%
Sales Q2Q%3.66%
3.2 Future
EUZ is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.42% yearly.
EUZ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.27% yearly.
EPS Next Y30.07%
EPS Next 2Y19.18%
EPS Next 3Y16.42%
EPS Next 5YN/A
Revenue Next Year8.76%
Revenue Next 2Y8.03%
Revenue Next 3Y8.27%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 26.54 indicates a quite expensive valuation of EUZ.
65.00% of the companies in the same industry are more expensive than EUZ, based on the Price/Earnings ratio.
EUZ is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.83, which is the current average of the S&P500 Index.
EUZ is valuated rather expensively with a Price/Forward Earnings ratio of 17.80.
66.67% of the companies in the same industry are more expensive than EUZ, based on the Price/Forward Earnings ratio.
EUZ is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 32.68, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.54 | ||
| Fwd PE | 17.8 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, EUZ is valued a bit cheaper than the industry average as 78.33% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, EUZ is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.52 | ||
| EV/EBITDA | 11.12 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of EUZ may justify a higher PE ratio.
EUZ's earnings are expected to grow with 16.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.88
PEG (5Y)3.07
EPS Next 2Y19.18%
EPS Next 3Y16.42%
5. Dividend
5.1 Amount
EUZ has a Yearly Dividend Yield of 1.05%. Purely for dividend investing, there may be better candidates out there.
The stock price of EUZ dropped by -46.73% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 2.13, EUZ pays a bit more dividend than its industry peers.
With a Dividend Yield of 1.05, EUZ pays less dividend than the S&P500 average, which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.05% |
5.2 History
The dividend of EUZ decreases each year by -43.97%.
Dividend Growth(5Y)-43.97%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
31.30% of the earnings are spent on dividend by EUZ. This is a low number and sustainable payout ratio.
DP31.3%
EPS Next 2Y19.18%
EPS Next 3Y16.42%
FRA:EUZ (11/7/2025, 7:00:00 PM)
15.66
-0.23 (-1.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners28.66%
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner ChangeN/A
Market Cap994.72M
Revenue(TTM)299.27M
Net Income(TTM)36.64M
Analysts82.86
Price Target22.92 (46.36%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.05% |
Yearly Dividend0.02
Dividend Growth(5Y)-43.97%
DP31.3%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.05%
PT rev (3m)-66.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-65.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.54 | ||
| Fwd PE | 17.8 | ||
| P/S | 3.32 | ||
| P/FCF | 17.52 | ||
| P/OCF | 13.28 | ||
| P/B | 4.43 | ||
| P/tB | 5.59 | ||
| EV/EBITDA | 11.12 |
EPS(TTM)0.59
EY3.77%
EPS(NY)0.88
Fwd EY5.62%
FCF(TTM)0.89
FCFY5.71%
OCF(TTM)1.18
OCFY7.53%
SpS4.71
BVpS3.54
TBVpS2.8
PEG (NY)0.88
PEG (5Y)3.07
Graham Number6.85
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.35% | ||
| ROE | 16.32% | ||
| ROCE | 17.92% | ||
| ROIC | 12.73% | ||
| ROICexc | 18.45% | ||
| ROICexgc | 22.68% | ||
| OM | 21.68% | ||
| PM (TTM) | 12.24% | ||
| GM | 47.96% | ||
| FCFM | 18.97% |
ROA(3y)6.9%
ROA(5y)7.6%
ROE(3y)13.51%
ROE(5y)14.72%
ROIC(3y)9.92%
ROIC(5y)9.15%
ROICexc(3y)13.44%
ROICexc(5y)13%
ROICexgc(3y)17.78%
ROICexgc(5y)17.59%
ROCE(3y)13.96%
ROCE(5y)12.89%
ROICexgc growth 3Y11.22%
ROICexgc growth 5Y1.55%
ROICexc growth 3Y17.53%
ROICexc growth 5Y5.68%
OM growth 3Y9.05%
OM growth 5Y5.71%
PM growth 3Y-16.23%
PM growth 5Y-1.83%
GM growth 3Y-1.4%
GM growth 5Y-0.15%
F-Score7
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 0.86 | ||
| Debt/EBITDA | 0.47 | ||
| Cap/Depr | 89.91% | ||
| Cap/Sales | 6.07% | ||
| Interest Coverage | 77.32 | ||
| Cash Conversion | 88.08% | ||
| Profit Quality | 154.92% | ||
| Current Ratio | 3.04 | ||
| Quick Ratio | 3 | ||
| Altman-Z | 4.87 |
F-Score7
WACC7.02%
ROIC/WACC1.81
Cap/Depr(3y)190.39%
Cap/Depr(5y)187.58%
Cap/Sales(3y)10.17%
Cap/Sales(5y)10.1%
Profit Quality(3y)67.54%
Profit Quality(5y)69.62%
High Growth Momentum
Growth
EPS 1Y (TTM)16.02%
EPS 3Y-1.23%
EPS 5Y8.65%
EPS Q2Q%24.4%
EPS Next Y30.07%
EPS Next 2Y19.18%
EPS Next 3Y16.42%
EPS Next 5YN/A
Revenue 1Y (TTM)9.42%
Revenue growth 3Y17.92%
Revenue growth 5Y10.63%
Sales Q2Q%3.66%
Revenue Next Year8.76%
Revenue Next 2Y8.03%
Revenue Next 3Y8.27%
Revenue Next 5YN/A
EBIT growth 1Y12.09%
EBIT growth 3Y28.59%
EBIT growth 5Y16.95%
EBIT Next Year50.24%
EBIT Next 3Y21.7%
EBIT Next 5YN/A
FCF growth 1Y272.16%
FCF growth 3Y114.55%
FCF growth 5Y8.28%
OCF growth 1Y70.09%
OCF growth 3Y25.28%
OCF growth 5Y10.49%
ECKERT & ZIEGLER SE / EUZ.DE FAQ
What is the fundamental rating for EUZ stock?
ChartMill assigns a fundamental rating of 7 / 10 to EUZ.DE.
What is the valuation status for EUZ stock?
ChartMill assigns a valuation rating of 6 / 10 to ECKERT & ZIEGLER SE (EUZ.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for ECKERT & ZIEGLER SE?
ECKERT & ZIEGLER SE (EUZ.DE) has a profitability rating of 8 / 10.
What is the financial health of ECKERT & ZIEGLER SE (EUZ.DE) stock?
The financial health rating of ECKERT & ZIEGLER SE (EUZ.DE) is 9 / 10.
What is the earnings growth outlook for ECKERT & ZIEGLER SE?
The Earnings per Share (EPS) of ECKERT & ZIEGLER SE (EUZ.DE) is expected to grow by 30.07% in the next year.